Gene Expression Changes Associated With Recurrence After Gross Total Resection of Newly Diagnosed World Health Organization Grade 1 Meningioma
Gene expression profiling may help to identify newly diagnosed WHO grade 1 meningiomas that have an elevated risk of recurrence despite GTR.
Authors
- Calixto‐Hope G. Lucas (ORCID: https://orcid.org/0000-0002-8347-9592)
- David Ronan Raleigh (ORCID: https://orcid.org/0000-0001-9299-8864)
- Mark W. Youngblood (ORCID: https://orcid.org/0000-0002-1044-8015)
- Ramin A. Morshed (ORCID: https://orcid.org/0000-0001-8464-6041)
- Joshua D. Palmer (ORCID: https://orcid.org/0000-0003-3311-0129)
- Philip V. Theodosopoulos (ORCID: https://orcid.org/0000-0002-8311-4729)
- Stephen T. Magill (ORCID: https://orcid.org/0000-0002-5257-7835)
- Haley Kopp Perlow (ORCID: https://orcid.org/0000-0001-8667-0782)
- William C. Chen (ORCID: https://orcid.org/0000-0001-8924-5853)
- Akash J. Patel (ORCID: https://orcid.org/0000-0002-1280-2989)
- Minh Nguyen (ORCID: https://orcid.org/0000-0001-9665-7629)
- James P. Chandler
Institutions
- Northwestern University (US)
- Johns Hopkins University (US)
- University of California, San Francisco (US)
- Baylor College of Medicine (US)
- Neurological Research Institute (US)
- Texas Children's Hospital (US)
- Neurological Surgery (US)
- The Ohio State University (US)
Publication Details
- Journal
- Neurosurgery
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1227/neu.0000000000003133
- Citations
- 5
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 1.93
Funders
- Foundation for the National Institutes of Health